Recent Finacing
Recent Raise
ImmuneID uses a platform combining next-generation sequencing, robotic automation, and AI to perform massively parallel antibody-interaction profiling and develop precision immunology therapeutics for autoimmunity, allergy, oncology, and infectious disease.
